Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis (MS), treatment with nonmyeloablative hematopoietic stem cell transplantation (low intensity stem cell transplantation) was associated with improvement in measures of disability and quality of life, according to a study in JAMA. Fifty percent of patients with MS are unable to continue employment by 10 years from diagnosis or are unable to walk … Continue reading Stem cell transplant lessens brain lesions associated with Multiple Sclerosis in human trials.